Related Experiment Video
Updated: Jan 15, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.1K
Challenges Remaining for Yttrium-90 Radioembolization: The Case for Standardized Dosimetry and Comparative Local
Christopher H Crane1, Theodore S Hong2, Freddy E Escorcia3
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Summary
No abstract available in PubMed .

